Successful Completion of Institutional Entitlement Offer
Filed with ASX · · 5 pages · English
Lumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- Target Market Determination
- Operational Update and Accelerated Entitlement Offer
- Operational Review & Management Reorganisation
- FebriDx Update - Brazil Market Authorisation & New Study
- FY2022 Half Year Update
Later from Lumos Diagnostics
- Lumos secures initial development services contract
- Lumos Diagnostics Appoints Doug Ward as CEO
- Security Class Suspension from Quotation LDXO
- ViraDx Receives Interim Order Authorisation in Canada
- Security Class Reinstatement of Quotation LDXO
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics